INVESTOR INFORMATION: A GROWING OPPORTUNITY

Diagnostic-driven therapies are changing what biopharma needs from commercialization. They depend on timely testing, clearer pathway intelligence, and more precise engagement across the treatment journey. Diaceutics brings intelligence and engagement together to help biopharma teams turn complex pathway signals into coordinated commercial action. With the scale to support more than 700 therapies, we combine diagnostic data, AI-powered pathway intelligence, deeply connected lab network relationships and commercialization expertise to support
launch, scale and adoption.